Gold Rate

Nectar Lifesciences Ltd.

BSE: 532649 | NSE: NECLIFE |

Shares falling in the `Trade-to-Trade` or `T-segment` are traded in this series and no intraday is allowed. This means trades can only be settled by accepting or giving the delivery of shares.

Series: BE | ISIN: INE023H01027 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Nectar Lifesci Nectar Lifesciences Ltd. | BSE 18.61 -0.40 (-2.10%) | NSE 18.68 -0.29 (-1.53%) | Trade | Add

BSE Live

Jan 08, 16:01

18.61 -0.40 (-2.10%)

Volume

AVERAGE VOLUME

5-Day

63,583

10-Day

59,322

30-Day

465,521

38,801

Prev. Close

19.01
Open Price

18.76

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

NSE Live

Jan 08, 15:58

18.68 -0.29 (-1.53%)

Volume

AVERAGE VOLUME

5-Day

368,279

10-Day

362,912

30-Day

4,558,469

114,689

Prev. Close

18.97
Open Price

18.92

Bid Price (Qty.)
18.68 (6)
Offer Price (Qty.)
0.00 (0)

Financials

Print/Copy to Excel : Go

Cash Flow of Nectar Lifesciences (in Rs. Cr.)	Mar 20	Mar 19	Mar 18	Mar 17	Mar 16
	12 mths	12 mths	12 mths	12 mths	12 mths
Net Profit/Loss Before Extraordinary Items And Tax	37.47	58.82	62.68	67.42	64.74
Net CashFlow From Operating Activities	284.96	239.24	65.17	198.76	168.82
Net Cash Used In Investing Activities	-33.13	-26.13	-29.44	-18.10	-76.88
Net Cash Used From Financing Activities	-251.87	-201.09	-39.60	-204.12	-88.68
Foreign Exchange Gains / Losses	0.00	0.00	0.00	0.00	0.00
Adjustments On Amalgamation Merger Demerger Others	0.00	0.00	0.00	0.00	0.00
Net Inc/Dec In Cash And Cash Equivalents	-0.03	12.02	-3.87	-23.47	3.27
Cash And Cash Equivalents Begin of Year	21.33	9.31	13.18	36.65	33.38
Cash And Cash Equivalents End Of Year	21.29	21.33	9.31	13.18	36.65